- Home
- SOHO vs ALLR Comparison
SOHO vs ALLR Comparison
Compare SOHO & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- ALLR
- Stock Information
- Founded
- SOHO 2004
- ALLR 2004
- Country
- SOHO United States
- ALLR United States
- Employees
- SOHO N/A
- ALLR N/A
- Industry
- SOHO Real Estate Investment Trusts
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- SOHO Real Estate
- ALLR Health Care
- Exchange
- SOHO Nasdaq
- ALLR Nasdaq
- Market Cap
- SOHO 15.4M
- ALLR 15.8M
- IPO Year
- SOHO 2004
- ALLR N/A
- Fundamental
- Price
- SOHO $0.87
- ALLR $1.05
- Analyst Decision
- SOHO Hold
- ALLR
- Analyst Count
- SOHO 1
- ALLR 0
- Target Price
- SOHO $1.50
- ALLR N/A
- AVG Volume (30 Days)
- SOHO 43.0K
- ALLR 414.7K
- Earning Date
- SOHO 08-12-2025
- ALLR 08-04-2025
- Dividend Yield
- SOHO N/A
- ALLR N/A
- EPS Growth
- SOHO N/A
- ALLR N/A
- EPS
- SOHO N/A
- ALLR N/A
- Revenue
- SOHO $182,158,199.00
- ALLR N/A
- Revenue This Year
- SOHO $13.93
- ALLR N/A
- Revenue Next Year
- SOHO N/A
- ALLR N/A
- P/E Ratio
- SOHO N/A
- ALLR N/A
- Revenue Growth
- SOHO 3.11
- ALLR N/A
- 52 Week Low
- SOHO $0.59
- ALLR $0.61
- 52 Week High
- SOHO $1.54
- ALLR $7.45
- Technical
- Relative Strength Index (RSI)
- SOHO 44.07
- ALLR 58.87
- Support Level
- SOHO $0.94
- ALLR $0.95
- Resistance Level
- SOHO $1.04
- ALLR $1.09
- Average True Range (ATR)
- SOHO 0.09
- ALLR 0.07
- MACD
- SOHO -0.02
- ALLR 0.01
- Stochastic Oscillator
- SOHO 18.52
- ALLR 86.44
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.